These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 3461207)
1. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. Gabizon A; Meshorer A; Barenholz Y J Natl Cancer Inst; 1986 Aug; 77(2):459-69. PubMed ID: 3461207 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465 [TBL] [Abstract][Full Text] [Related]
3. Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity. Zou Y; Priebe W; Stephens LC; Perez-Soler R Clin Cancer Res; 1995 Nov; 1(11):1369-74. PubMed ID: 9815933 [TBL] [Abstract][Full Text] [Related]
4. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
5. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Gabizon AA Cancer Res; 1992 Feb; 52(4):891-6. PubMed ID: 1737351 [TBL] [Abstract][Full Text] [Related]
6. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes. Working PK; Newman MS; Sullivan T; Yarrington J J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696 [TBL] [Abstract][Full Text] [Related]
7. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice. Chan P Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179 [TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
9. Protective role of grape seed extract against doxorubicin-induced cardiotoxicity and genotoxicity in albino mice. Yalçin E; Oruç E; Cavuşoğlu K; Yapar K J Med Food; 2010 Aug; 13(4):917-25. PubMed ID: 20553142 [TBL] [Abstract][Full Text] [Related]
10. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126 [TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
12. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389 [TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287 [TBL] [Abstract][Full Text] [Related]
14. Vascular targeting of doxorubicin using cationic liposomes. Wu J; Lee A; Lu Y; Lee RJ Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230 [TBL] [Abstract][Full Text] [Related]
15. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. van Hoesel QG; Steerenberg PA; Crommelin DJ; van Dijk A; van Oort W; Klein S; Douze JM; de Wildt DJ; Hillen FC Cancer Res; 1984 Sep; 44(9):3698-705. PubMed ID: 6744286 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice. Bruynzeel AM; Vormer-Bonne S; Bast A; Niessen HW; van der Vijgh WJ Cancer Chemother Pharmacol; 2007 Sep; 60(4):509-14. PubMed ID: 17177067 [TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Wong HL; Rauth AM; Bendayan R; Wu XY Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986 [TBL] [Abstract][Full Text] [Related]
18. Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation. Herman EH; Rahman A; Ferrans VJ; Vick JA; Schein PS Cancer Res; 1983 Nov; 43(11):5427-32. PubMed ID: 6616474 [TBL] [Abstract][Full Text] [Related]
19. Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38. Mayhew EG; Goldrosen MH; Vaage J; Rustum YM J Natl Cancer Inst; 1987 Apr; 78(4):707-13. PubMed ID: 3470546 [TBL] [Abstract][Full Text] [Related]
20. Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs. Kanter PM; Bullard GA; Pilkiewicz FG; Mayer LD; Cullis PR; Pavelic ZP In Vivo; 1993; 7(1):85-95. PubMed ID: 8504212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]